Albusta, N.; Isa, S.; Alrahma, H.
Lean Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD): Pathophysiology, Diagnostic Challenges, Clinical Outcomes, and Management. Diseases 2026, 14, 173.
https://doi.org/10.3390/diseases14050173
AMA Style
Albusta N, Isa S, Alrahma H.
Lean Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD): Pathophysiology, Diagnostic Challenges, Clinical Outcomes, and Management. Diseases. 2026; 14(5):173.
https://doi.org/10.3390/diseases14050173
Chicago/Turabian Style
Albusta, Noor, Sara Isa, and Hussain Alrahma.
2026. "Lean Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD): Pathophysiology, Diagnostic Challenges, Clinical Outcomes, and Management" Diseases 14, no. 5: 173.
https://doi.org/10.3390/diseases14050173
APA Style
Albusta, N., Isa, S., & Alrahma, H.
(2026). Lean Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD): Pathophysiology, Diagnostic Challenges, Clinical Outcomes, and Management. Diseases, 14(5), 173.
https://doi.org/10.3390/diseases14050173